国元证券(000728)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

000728 国元证券

已收盘 05-17 15:00:00

{"stockData":{"symbol":"000728","market":"SZ","secType":"STK","nameCN":"国元证券","latestPrice":6.81,"timestamp":1715929419000,"preClose":6.72,"halted":0,"volume":28612359,"delay":0,"floatShares":4364000000,"shares":4364000000,"eps":0.415,"marketStatus":"已收盘","marketStatusCode":5,"change":0.09,"latestTime":"05-17 15:00:00","open":6.71,"high":6.81,"low":6.7,"amount":193000000,"amplitude":0.0164,"askPrice":6.81,"askSize":7461,"bidPrice":6.8,"bidSize":4440,"shortable":0,"etf":0,"ttmEps":0.415,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1716168600000},"adr":0,"adjPreClose":6.72,"symbolType":"stock","openAndCloseTimeList":[[1715909400000,1715916600000],[1715922000000,1715929200000]],"highLimit":7.39,"lowLimit":6.05,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":4363777891,"pbRate":0.83,"roa":"--","roe":"1.33%","epsLYR":0.43,"committee":-0.169403,"marketValue":29717000000,"floatMarketCap":29717000000,"peRate":16.409639,"changeRate":0.0134,"turnoverRate":0.0066,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-05-20。"},"requestUrl":"/m/hq/s/000728/tweets","defaultTab":"tweets","newsList":[{"id":"2436998984","title":"科兴制药涨5.79%，国元证券一周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2436998984","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2436998984?lang=zh_cn&edition=full","pubTime":"2024-05-17 16:24","pubTimestamp":1715934249,"startTime":"0","endTime":"0","summary":"今日科兴制药涨5.79%，收盘报19.92元。2024年5月10日，国元证券研究员马云涛,朱仕平发布了对科兴制药的研报《2023年报及2024一季度报告点评：海外商业化不断推进，看好业绩高增长》，该研报对科兴制药给出“买入”评级。维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为79.7%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为国元证券的朱仕平、马云涛。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171631138b11d447&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405171631138b11d447&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2435643350","title":"国元证券：给予海泰新光买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2435643350","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435643350?lang=zh_cn&edition=full","pubTime":"2024-05-16 12:35","pubTimestamp":1715834121,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司马云涛近期对海泰新光进行研究并发布了研究报告《首次覆盖报告：聚焦荧光硬镜赛道，整机业务未来可期》，本报告对海泰新光给出买入评级，当前股价为45.0元。首次覆盖，给予公司“买入”的投资评级。最新盈利预测明细如下：该股最近90天内共有18家机构给出评级，买入评级14家，增持评级4家；过去90天内机构目标均价为53.0。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051600015758.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435122637","title":"国元证券：给予潮宏基买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2435122637","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435122637?lang=zh_cn&edition=full","pubTime":"2024-05-15 20:50","pubTimestamp":1715777425,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司李典近期对潮宏基进行研究并发布了研究报告《2023年年报及2024年一季报点评：24Q1高基数下维持稳健增长，加盟拓展积极推进》，本报告对潮宏基给出买入评级，当前股价为6.03元。我们预计2024-2026EPS为0.45/0.53/0.60元，对应PE为13/11/10x，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有25家机构给出评级，买入评级17家，增持评级7家，中性评级1家；过去90天内机构目标均价为7.83。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500036205.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435384826","title":"国元证券：给予恺英网络买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2435384826","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435384826?lang=zh_cn&edition=full","pubTime":"2024-05-15 18:30","pubTimestamp":1715769048,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司李典近期对恺英网络进行研究并发布了研究报告《2023年报及2024年一季报点评：业绩表现亮眼，分红回购增厚投资回报》，本报告对恺英网络给出买入评级，当前股价为11.65元。　　恺英网络　　事件：　　公司发布2023年年报及2024年一季报。最新盈利预测明细如下：该股最近90天内共有25家机构给出评级，买入评级22家，增持评级3家；过去90天内机构目标均价为15.9。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500031475.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435638484","title":"国元证券：给予昆仑万维增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2435638484","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435638484?lang=zh_cn&edition=full","pubTime":"2024-05-15 18:30","pubTimestamp":1715769047,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司李典近期对昆仑万维进行研究并发布了研究报告《2023年年报及2024年一季报点评：Opera保持高增长，AGI战略持续推进》，本报告对昆仑万维给出增持评级，当前股价为37.03元。公司23年8月推出首款国内AI搜索产品天工AI搜索，已经积累上百亿的优质数据资源。最新盈利预测明细如下：该股最近90天内共有8家机构给出评级，买入评级5家，增持评级3家；过去90天内机构目标均价为52.2。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051500031472.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435056488","title":"国元证券：给予双杰电气增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2435056488","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435056488?lang=zh_cn&edition=full","pubTime":"2024-05-14 16:32","pubTimestamp":1715675566,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司龚斯闻近期对双杰电气进行研究并发布了研究报告《公司首次覆盖报告：输配电业务恢复性增长，新能源业务成长可期》，本报告对双杰电气给出增持评级，当前股价为6.96元。2023年公司输配电业务整体营收17.27亿元，同比增长28.18%。我们预计公司2024-2026年归母净利润分别为4.35/5.46/6.72亿元，对应PE分别为13.2/10.5/8.5倍，首次覆盖给予“增持”评级。最新盈利预测明细如下：该股最近90天内共有1家机构给出评级，买入评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400023094.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435615675","title":"天地数码涨7.44%，国元证券二日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2435615675","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435615675?lang=zh_cn&edition=full","pubTime":"2024-05-14 16:19","pubTimestamp":1715674760,"startTime":"0","endTime":"0","summary":"今日天地数码涨7.44%，收盘报13.29元。2024年5月12日，国元证券研究员耿军军发布了对天地数码的研报《2023年报及2024年一季报点评：盈利能力显著提升，经营战略有效落地》，该研报对天地数码给出“买入”评级。考虑到行业的成长空间和公司业务的持续成长性，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为国元证券的耿军军。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051400022054.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435320537","title":"国元证券：截至2024年5月10日，公司股东人数104519户","url":"https://stock-news.laohu8.com/highlight/detail?id=2435320537","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435320537?lang=zh_cn&edition=full","pubTime":"2024-05-13 21:01","pubTimestamp":1715605266,"startTime":"0","endTime":"0","summary":"证券之星消息，国元证券(000728)05月13日在投资者关系平台上答复投资者关心的问题。投资者：董秘 你好 截止5月10号 股东人数多少国元证券董秘：尊敬的投资者，您好！截至2024年5月10日，公司股东人数104519户。投资者：你好，请问截止到2024年5月10日公司股东人数是多少？谢谢。国元证券董秘：尊敬的投资者，您好！截至2024年5月10日，公司股东人数104519户。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051300025771.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2435346795","title":"迈普医学涨7.24%，国元证券二周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2435346795","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2435346795?lang=zh_cn&edition=full","pubTime":"2024-05-13 16:24","pubTimestamp":1715588677,"startTime":"0","endTime":"0","summary":"今日迈普医学涨7.24%，收盘报42.36元。2024年4月26日，国元证券研究员马云涛,朱仕平发布了对迈普医学的研报《2023年报及2024一季度报告点评：集采有望加速产品渗透，新产品大放异彩》，该研报对迈普医学给出“买入”评级。维持“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为72.55%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为天风证券的张雪、杨松。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051300014930.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434382877","title":"皖新传媒获国元证券买入评级，核心主业稳健增长，数字化升级值得期待","url":"https://stock-news.laohu8.com/highlight/detail?id=2434382877","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2434382877?lang=zh_cn&edition=full","pubTime":"2024-05-12 14:14","pubTimestamp":1715494460,"startTime":"0","endTime":"0","summary":"5月12日，皖新传媒获国元证券买入评级，近一个月皖新传媒获得8份研报关注。研报预计2024-2026年公司实现归母净利润7.75/9.69/11.48亿元。研报认为，公司深耕安徽，核心教材教辅发行业务经营稳健，AI+教育、智慧校园等多赛道布局有望贡献业绩新增量。风险提示：宏观经济下行风险；新业务拓展不及预期风险；行业竞争加剧风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240512141422875daedb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240512141422875daedb&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434384290","title":"药康生物获国元证券买入评级，收入保持稳健增长，看好未来业绩增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2434384290","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2434384290?lang=zh_cn&edition=full","pubTime":"2024-05-12 14:14","pubTimestamp":1715494453,"startTime":"0","endTime":"0","summary":"5月12日，药康生物获国元证券买入评级，近一个月药康生物获得8份研报关注。研报预计“斑点鼠”、“药筛鼠”等项目的快速推进，公司商品化小鼠品系资源不断丰富，叠加公司布点的推进和开拓力度的加大，看好公司业绩持续修复。研报认为，公司持续高强度投入研发，持续推进“野化鼠计划”、“无菌鼠及悉生鼠计划”、“斑点鼠计划”、“药筛鼠计划”等多个研发项目，看好公司未来业绩增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405121414178afd5242&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405121414178afd5242&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434412384","title":"国元证券：给予华康医疗买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2434412384","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434412384?lang=zh_cn&edition=full","pubTime":"2024-05-12 14:10","pubTimestamp":1715494225,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司马云涛,朱仕平近期对华康医疗进行研究并发布了研究报告《2023年报及2024一季度报告点评：聚焦两主三副，打造医疗净化行业标杆》，本报告对华康医疗给出买入评级，当前股价为20.26元。　　华康医疗　　事件：　　华康医疗于近期发布2023年及2024年一季度报告：2023年公司实现收入16.0亿，主要来自于医疗净化系统集成业务和医疗耗材销售；归母净利润1.1亿，扣非归母净利润9084.4万。维持“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051200001429.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434538467","title":"国元证券：给予皖新传媒买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2434538467","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434538467?lang=zh_cn&edition=full","pubTime":"2024-05-12 14:02","pubTimestamp":1715493759,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司李典近期对皖新传媒进行研究并发布了研究报告《2023年年报及2024年一季报点评：核心主业稳健增长，数字化升级值得期待》，本报告对皖新传媒给出买入评级，当前股价为7.38元。我们预计2024-2026年公司实现归母净利润7.75/9.69/11.48亿元，EPS分别为0.39/0.49/0.58元，对应PE19/15/13倍，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有7家机构给出评级，买入评级5家，增持评级2家；过去90天内机构目标均价为8.06。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051200001421.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434384676","title":"国元证券：给予药康生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2434384676","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434384676?lang=zh_cn&edition=full","pubTime":"2024-05-12 14:02","pubTimestamp":1715493745,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司马云涛,朱仕平近期对药康生物进行研究并发布了研究报告《2023年报及2024年一季度报告点评：收入保持稳健增长，看好未来业绩增长》，本报告对药康生物给出买入评级，当前股价为12.58元。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有11家机构给出评级，买入评级6家，增持评级5家；过去90天内机构目标均价为15.97。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051200001419.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434384678","title":"国元证券：给予蓝色光标买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2434384678","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434384678?lang=zh_cn&edition=full","pubTime":"2024-05-12 14:02","pubTimestamp":1715493732,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司李典,路璐近期对蓝色光标进行研究并发布了研究报告《2023年年报及2024年一季报点评：营收规模快速提升，出海与AI共驱成长》，本报告对蓝色光标给出买入评级，当前股价为6.22元。我们预计2024-2026年公司实现归母净利润3.66/4.96/6.31亿元，EPS分别为0.15/0.20/0.25元，对应PE42/31/25倍，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有12家机构给出评级，买入评级7家，增持评级4家，中性评级1家；过去90天内机构目标均价为6.52。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051200001417.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434814838","title":"国元证券：给予一品红买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2434814838","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434814838?lang=zh_cn&edition=full","pubTime":"2024-05-11 09:31","pubTimestamp":1715391060,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司马云涛近期对一品红进行研究并发布了研究报告《2023年报和2024Q1季报点评报告：创新研发持续加速，长期发展值得期待》，本报告对一品红给出买入评级，当前股价为22.93元。最新盈利预测明细如下：该股最近90天内共有6家机构给出评级，买入评级5家，增持评级1家；过去90天内机构目标均价为33.68。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051100016159.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434836256","title":"吉贝尔获国元证券买入评级，两大核心品种持续高速放量，看好业绩快速增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2434836256","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2434836256?lang=zh_cn&edition=full","pubTime":"2024-05-10 17:44","pubTimestamp":1715334279,"startTime":"0","endTime":"0","summary":"5月10日，吉贝尔获国元证券买入评级，近一个月吉贝尔获得2份研报关注。研报预计公司2024-2026年营收增速分别为24.81%/26.13%/24.18%；归母净利润增速为27.23%/27.46%/27.66%。研报认为，利可君片肿瘤科室的持续推进、尼群洛尔片在高血压伴高心率患者中渗透率的快速提升，预计公司业绩将快速增长。同时，公司积极推进新药研发，不断取得新成果，抗抑郁新药JJH201501和抗肿瘤新药JJH201601的研发进展顺利，有望成为新型抗抑郁症药物和抗肿瘤药物。风险提示：核心产品销售不及预期风险、新药研发失败风险、竞争环境恶化等风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051017444287503e52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024051017444287503e52&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2434188189","title":"唐兴科技IPO撤单：国元证券保荐，唐素文家族三人控股96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2434188189","media":"地产k线","top":-1,"share":"https://www.laohu8.com/m/news/2434188189?lang=zh_cn&edition=full","pubTime":"2024-05-10 15:37","pubTimestamp":1715326620,"startTime":"0","endTime":"0","summary":"日前，唐兴科技及保荐人国元证券股份有限公司分别向深交所提交了撤回申请文件，深交所决定终止对唐兴科技首次公开发行股票并在创业板上市的审核。唐兴科技控股股东、实际控制人为唐素文、唐夕明和马允树。唐素文和唐夕明系兄弟关系，马允树与唐素文、唐夕明系表兄弟关系，且三人已签署《一致行动人协议》，合计控制公司95.94%的股份表决权，持股高度集中，为公司控股股东、实际控制人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-05-10/doc-inautsin8679856.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-05-10/doc-inautsin8679856.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2434008852","title":"国元证券：给予口子窖买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2434008852","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2434008852?lang=zh_cn&edition=full","pubTime":"2024-05-10 10:55","pubTimestamp":1715309738,"startTime":"0","endTime":"0","summary":"国元证券股份有限公司邓晖,朱宇昊近期对口子窖进行研究并发布了研究报告《口子窖2023年报及2024一季报点评：产品结构升级，稳健增长》，本报告对口子窖给出买入评级，当前股价为43.0元。　　投资建议　　我们预计公司24/25/26年归母净利为20.05/23.12/26.42亿元，增速16.46%/15.32%/14.30%，对应5月8日PE13/11/10倍，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有17家机构给出评级，买入评级10家，增持评级7家；过去90天内机构目标均价为49.35。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024051000020655.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1997-06-16","address":"安徽省合肥市蜀山区梅山路18号","stockEarnings":[{"period":"1week","weight":-0.0029},{"period":"1month","weight":0.0542},{"period":"3month","weight":0.0149},{"period":"6month","weight":-0.0408},{"period":"1year","weight":-0.0067},{"period":"ytd","weight":-0.0029}],"companyName":"国元证券股份有限公司","boardCode":"AI0067","perCapita":"41751股","boardName":"资本市场服务","registeredCapital":"436377万元","compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.0269},{"period":"3month","weight":0.1005},{"period":"6month","weight":0.0326},{"period":"1year","weight":-0.0435},{"period":"ytd","weight":0.0602}],"survey":"　　国元证券股份有限公司的主要业务为财富信用业务、自营业务、投资银行业务、资产管理业务、机构业务、国际业务。公司荣获第十七届中国财经风云榜券商科技金融创新奖，新财富中国最佳投行榜单九项大奖等荣誉。","serverTime":1716036838779,"listedPrice":7.2,"stockholders":"104519人(较上一季度减少0.37%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国元证券(000728)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国元证券(000728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国元证券,000728,国元证券股票,国元证券股票老虎,国元证券股票老虎国际,国元证券行情,国元证券股票行情,国元证券股价,国元证券股市,国元证券股票价格,国元证券股票交易,国元证券股票购买,国元证券股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国元证券(000728)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国元证券(000728)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}